Watch Ticker

Adaptimmune Therapeutics plc American Depositary Shares

Go to Adaptimmune Therapeutics plc American Depositary Shares Website

$0.08

-0.01 (-13.25%)

Live

Previous Close

$0.0951

Day Range

$0.0811 - $0.0907

Previous Day Range

$0.091 - $0.12

Market Cap

$21.0 million USD

Day Vol.

27.5 million

Previous Day Vol.

430.5 million

Currency

USD

Primary Exchange

Nasdaq

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer target...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - LAG-3 Immunotherapies Market Set for Rapid Growth in the Coming 10 Years Across the 7MM as Next-Generation Therapies Advance | DelveInsight

The LAG-3 next-generation therapies market is expected to grow significantly in the coming years due to the potential entry of major LAG-3 candidates, increase in incident cases of various solid tumors, and improvement in patient outcomes.

Related tickers: MRK, ADAP, REGN, IMMP.

Read Full Article

Proactive Investors - Biotechnology acquisitions could impact FDA decisions to watch in Q3 By Proactive Investors - Investing.com Australia

The FDA is expected to make several landmark decisions in Q3, including approvals for treatments for schizophrenia, PTSD, and liver disease. These decisions could be impacted by recent biotechnology acquisitions.

Related tickers: GILD, ASND, ADAP.

Read Full Article

Trending Tickers

Please sign in to view